Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models. (Q50702084)

17 March 2018

title

Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models. (English)

1 reference

17 March 2018

1 reference

7

1 reference

17 March 2018

Adrian C Lo

11

1 reference

17 March 2018

Sebastian Munck

18

1 reference

17 March 2018

Dick Swaab

20

1 reference

17 March 2018

John Anthony Hardy

21

object named as

John Hardy

1 reference

17 March 2018

17

Mina Ryten

1 reference

17 March 2018

23

Bart De Strooper

1 reference

17 March 2018

Yunhong Huang

1

1 reference

17 March 2018

Aneta Skwarek-Maruszewska

2

1 reference

17 March 2018

Katrien Horré

3

1 reference

17 March 2018

Elke Vandewyer

4

1 reference

17 March 2018

Leen Wolfs

5

1 reference

17 March 2018

An Snellinx

6

1 reference

17 March 2018

Enrico Radaelli

8

1 reference

17 March 2018

Nikky Corthout

9

1 reference

17 March 2018

Julien Colombelli

10

1 reference

17 March 2018

Leen Van Aerschot

12

1 reference

17 March 2018

Zsuzsanna Callaerts-Vegh

13

1 reference

17 March 2018

Daniah Trabzuni

14

1 reference

17 March 2018

Koen Bossers

15

1 reference

17 March 2018

Joost Verhaagen

16

1 reference

17 March 2018

Rudi D'Hooge

19

1 reference

17 March 2018

Takaomi C Saido

22

1 reference

17 March 2018

Amantha Thathiah

24

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 October 2015

1 reference

17 March 2018

Science Translational Medicine

published in

1 reference

17 March 2018

volume

7

1 reference

17 March 2018

issue

309

1 reference

17 March 2018

page(s)

309ra164

1 reference

17 March 2018

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Lessons from a failed γ-secretase Alzheimer trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

G-protein-coupled receptors at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Single App knock-in mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

GPR3 receptor, a novel actor in the emotional-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Prevalence of AD among whites: a summary by levels of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The prevalence of dementia: a quantitative integration of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Epidemiology of dementia in a Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The use of the elevated plus maze as an assay of anxiety-related behavior in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Loss of HDAC5 impairs memory function: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

CLARITY for mapping the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Structural and molecular interrogation of intact biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Inside Alzheimer brain with CLARITY: senile plaques, neurofibrillary tangles and axons in 3-D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Beta-arrestin-biased ligands at seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The Gs-linked receptor GPR3 inhibits the proliferation of cerebellar granule cells during postnatal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The orphan receptor GPR3 modulates the early phases of cocaine reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Premature ovarian aging in mice deficient for Gpr3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

A beta-arrestin 2 signaling complex mediates lithium action on behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Therapeutic potential of β-arrestin- and G protein-biased agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAB3492

10.1126/SCITRANSLMED.AAB3492

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018